MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Bruker Corporation Operating Expenses 2011-2026 | BRKR
Annual Operating Expenses Bruker Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.51 B | 1.4 B | 1.08 B | 873 M | 796 M | 678 M | 696 M | 631 M | 583 M | 546 M | 557 M | 646 M | 634 M | 649 M | 584 M | 448 M | 381 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.51 B | 381 M | 746 M |
Quarterly Operating Expenses Bruker Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 370 M | 431 M | 346 M | 359 M | - | 351 M | 336 M | 288 M | - | 258 M | 254 M | 237 M | - | 204 M | 224 M | 210 M | - | 196 M | 195 M | 190 M | - | 167 M | 148 M | 176 M | - | 166 M | 177 M | 173 M | - | 154 M | 156 M | 161 M | - | 148 M | 149 M | 139 M | - | 139 M | 150 M | 133 M | - | 139 M | 138 M | 145 M | - | 162 M | 165 M | 159 M | - | 162 M | 158 M | 162 M | - | 150 M | 166 M | 156 M | - | 152 M | 145 M | 136 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 431 M | 133 M | 197 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
301 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 11.68 | 2.05 % | $ 331 M | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
614 M | $ 8.26 | -0.18 % | $ 1.24 B | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
47.1 M | $ 4.36 | 1.28 % | $ 163 M |  France |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
249 M | $ 2.29 | - | $ 50.5 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.02 | 0.79 % | $ 17.3 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.48 | 4.14 % | $ 29.9 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 17.9 | -2.56 % | $ 420 M | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 10.97 | -0.45 % | $ 393 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
LENSAR
LNSR
|
32.6 M | $ 6.05 | -0.74 % | $ 72.3 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 75.17 | 1.81 % | $ 4.1 B |  Britain |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Pulmonx Corporation
LUNG
|
121 M | $ 1.52 | -2.26 % | $ 61.8 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
MiMedx Group
MDXG
|
277 M | $ 3.69 | 1.8 % | $ 545 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 37.15 | -2.8 % | $ 314 M | USA |
 |
Myomo
MYO
|
41.3 M | $ 1.03 | -0.48 % | $ 43.1 M | USA |
 |
Butterfly Network
BFLY
|
132 M | $ 4.6 | 2.8 % | $ 1.14 B | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Orthofix Medical
OFIX
|
344 M | $ 9.62 | -10.51 % | $ 381 M |  Curacao |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
887 M | $ 85.36 | 0.65 % | $ 11.5 B | USA |
 |
Profound Medical Corp.
PROF
|
52.6 M | $ 6.86 | 0.44 % | $ 207 M | Canada |
 |
Insulet Corporation
PODD
|
531 M | $ 155.0 | 0.08 % | $ 10.9 B | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 35.96 | -3.41 % | $ 1.12 B | USA |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.44 | 2.09 % | $ 6.77 M | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 42.74 | -2.51 % | $ 1.26 B | USA |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 89.8 | 0.58 % | $ 3.12 B | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 87.37 | 1.85 % | $ 51.1 B | USA |
 |
TransMedics Group
TMDX
|
254 M | $ 69.63 | 1.01 % | $ 2.37 B | USA |